{"id":"W2035077408","doi":"10.1111/j.1600-0609.2009.01230.x","title":"Rivaroxaban – an oral, direct Factor Xa inhibitor – lessons from a broad clinical study programme","year":2009,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bayer HealthCare; Bayer","keywords":"Rivaroxaban; Medicine; Dosing; Atrial fibrillation; Stroke (engine); Intensive care medicine; Apixaban; Venous thromboembolism; Internal medicine; Warfarin; Thrombosis","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003768264,0.000624069,0.001444732,0.001912987,0.0002783537,0.001412961,0.000933091,0.00146302,0.002701902],"category_scores_gemma":[0.003843362,0.000274756,0.0006357966,0.002214219,0.0009204605,0.002919329,0.0009677486,0.002558755,0.001669106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008665308,"about_ca_system_score_gemma":0.00265677,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007946395,"about_ca_topic_score_gemma":0.001485712,"domain_scores_codex":[0.9990516,0.0002273771,0.0001786605,0.0001038302,0.000405777,0.00003280022],"domain_scores_gemma":[0.997709,0.001150012,0.0001986654,0.0001045038,0.0006681582,0.0001696359],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007749863,0.00008337558,0.0001515601,0.01542956,0.00007827416,0.000174783,0.0001033769,0.0001631509,0.0008807343,0.006091116,0.05134087,0.9254256],"study_design_scores_gemma":[0.00008443862,0.0002000915,0.001612803,0.01738049,0.0001218098,0.001675466,0.0001271052,0.0001119269,0.0002333362,0.006618991,0.9718113,0.00002224671],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00015857,0.9932453,0.0002677576,0.003590196,0.0005641662,0.00001949231,0.00001152834,0.00001222889,0.002130694],"genre_scores_gemma":[0.001121527,0.9944432,0.0007930626,0.002226379,0.0005536049,0.00002049008,0.00002220621,0.000004182734,0.0008153247],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003768264,"threshold_uncertainty_score":0.01992875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3931665842578435,"score_gpt":0.5020525776786479,"score_spread":0.1088859934208044,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}